TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Oral Cancer Treatment Market, by Type
6.1 Introduction
6.2 Squamous Cell Carcinoma
Market Estimates & Forecast, 2023-2030
6.3 Verrucous Carcinoma
Market Estimates & Forecast, 2023-2030
6.4 Minor Salivary Gland Carcinomas
Market Estimates & Forecast, 2023-2030
6.5 Lymphomas
Market Estimates & Forecast, 2023-2030
6.6 Others
Chapter 7. Global Oral Cancer Treatment Market, by Treatment
7.1 Introduction
7.2 Surgery
Market Estimates & Forecast, 2023-2030
7.2.1 Tumor Resection
7.2.2 Glossectomy
7.2.3 Laryngectomy
7.2.4 Mohs Micrographic Surgery
7.2.5 Others
7.3 Radiotherapy
Market Estimates & Forecast, 2023-2030
7.4 Chemotherapy
Market Estimates & Forecast, 2023-2030
7.4.1 Cisplatin
7.4.2 Carboplatin
7.4.3 5-fluorouracil (5-FU)
7.4.4 Others
7.5 Photodynamic Therapy (PDT)
Market Estimates & Forecast, 2023-2030
7.6 Others
Chapter 8. Global Oral Cancer Treatment Market, by End Users
8.1 Introduction
8.2 Hospitals & Clinics
Market Estimates & Forecast, 2023-2030
8.3 Research Organization
Market Estimates & Forecast, 2023-2030
8.4 Academic Institutes
Market Estimates & Forecast, 2023-2030
8.5 Others
Chapter 9. Global Oral Cancer Treatment Market, by Region
9.1 Introduction
9.2 America
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 U.K
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia Pacific
9.5 The Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Oman
9.5.4 Kuwait
9.5.5 Qatar
9.5.6 Rest of the Middle East & Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments
Chapter 11 Company Profiles
11.1 Bristol-Myers Squibb Company
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials
11.2.4 Key Developments
11.1.5 SWOT Analysis
11.2 Qilu Pharmaceutical Co., Ltd.
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Teva Pharmaceutical Industries Ltd.
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Eli Lilly and Company.
11.4.1 Company Overview
11.4.2 Product/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 F. Hoffmann-La Roche Ltd
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Merck & Co., Inc.
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Novartis AG
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Pfizer Inc.
11.8.1 Overview
11.8.2 Product Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Others
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of Oral Cancer Industry
Chapter 13 Appendix
LIST OF TABLES
Table 1 Oral Cancer Treatment Industry Synopsis, 2023-2030
Table 2 Global Oral Cancer Treatment Market Estimates and Forecast, 2023-2030, (USD Million)
Table 3 Global Oral Cancer Treatment Market by Region, 2023-2030, (USD Million)
Table 4 Global Oral Cancer Treatment Market by Type, 2023-2030, (USD Million)
Table 5 Global Oral Cancer Treatment Market by Treatment, 2023-2030, (USD Million)
Table 6 Global Oral Cancer Treatment Market by End Users, 2023-2030, (USD Million)
Table 7 North America Oral Cancer Treatment Market by Type, 2023-2030, (USD Million)
Table 8 North America Oral Cancer Treatment by Treatment, 2023-2030, (USD Million)
Table 9 North America Oral Cancer Treatment by End Users, 2023-2030, (USD Million)
Table 10 U.S. Oral Cancer Treatment Market by Type, 2023-2030, (USD Million)
Table 11 U.S. Oral Cancer Treatment Market by Treatment, 2023-2030, (USD Million)
Table 12 U.S. Oral Cancer Treatment Market by End Users, 2023-2030, (USD Million)
Table 13 Canada Oral Cancer Treatment Market by Type, 2023-2030, (USD Million)
Table 14 Canada Oral Cancer Treatment Market by Treatment, 2023-2030, (USD Million)
Table 15 Canada Oral Cancer Treatment Market by End Users, 2023-2030, (USD Million)
Table 16 South America Oral Cancer Treatment Market by Type, 2023-2030, (USD Million)
Table 17 South America Oral Cancer Treatment Market by Treatment, 2023-2030, (USD Million)
Table 18 South America Oral Cancer Treatment Market by End Users, 2023-2030, (USD Million)
Table 19 Europe Oral Cancer Treatment Market by Type, 2023-2030, (USD Million)
Table 20 Europe Oral Cancer Treatment Market by Treatment, 2023-2030, (USD Million)
Table 21 Europe Oral Cancer Treatment Market by End Users, 2023-2030, (USD Million)
Table 22 Western Europe Oral Cancer Treatment Market by Type, 2023-2030, (USD Million)
Table 23 Western Europe Oral Cancer Treatment Market by Treatment, 2023-2030, (USD Million)
Table 24 Western Europe Oral Cancer Treatment Market by End Users, 2023-2030, (USD Million)
Table 25 Eastern Europe Oral Cancer Treatment Market by Type, 2023-2030, (USD Million)
Table 26 Eastern Europe Oral Cancer Treatment Market by Treatment, 2023-2030, (USD Million)
Table 27 Eastern Europe Oral Cancer Treatment Market by End Users, 2023-2030, (USD Million)
Table 28 Asia Pacific Oral Cancer Treatment Market by Type, 2023-2030, (USD Million)
Table 29 Asia Pacific Oral Cancer Treatment Market by Treatment, 2023-2030, (USD Million)
Table 30 Asia Pacific Oral Cancer Treatment Market by End Users, 2023-2030, (USD Million)
Table 31 Middle East & Africa Oral Cancer Treatment Market by Type, 2023-2030, (USD Million)
Table 32 Middle East & Africa Oral Cancer Treatment Market by Treatment, 2023-2030, (USD Million)
Table 33 Middle East & Africa Oral Cancer Treatment Market by End Users, 2023-2030, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Oral Cancer Treatment Market
Figure 3 Market Dynamics for Global Oral Cancer Treatment Market
Figure 4 Global Oral Cancer Treatment Market Share, by Type 2023
Figure 5 Global Oral Cancer Treatment Market Share, by Treatment 2023
Figure 6 Global Oral Cancer Treatment Market Share, by End Users, 2023
Figure 7 Global Oral Cancer Treatment Market Share, by Region, 2023
Figure 8 North America Oral Cancer Treatment Market Share, by Country, 2023
Figure 9 Europe Oral Cancer Treatment Market Share, by Country, 2023
Figure 10 Asia Pacific Oral Cancer Treatment Market Share, by Country, 2023
Figure 11 Middle East & Africa Oral Cancer Treatment Market Share, by Country, 2023
Figure 12 Global Oral Cancer Treatment Market: Company Share Analysis, 2023 (%)
Figure 13 Bristol-Myers Squibb Company: Key Financials
Figure 14 Bristol-Myers Squibb Company: Segmental Revenue
Figure 15 Bristol-Myers Squibb Company: Geographical Revenue
Figure 16 Qilu Pharmaceutical Co., Ltd.: Key Financials
Figure 17 Qilu Pharmaceutical Co., Ltd.: Segmental Revenue
Figure 18 Qilu Pharmaceutical Co., Ltd.: Geographical Revenue
Figure 19 Teva Pharmaceutical Industries Ltd.: Key Financials
Figure 20 Teva Pharmaceutical Industries Ltd.: Segmental Revenue
Figure 21 Teva Pharmaceutical Industries Ltd.: Geographical Revenue
Figure 22 Eli Lilly and Company.: Key Financials
Figure 23 Eli Lilly and Company.: Segmental Revenue
Figure 24 Eli Lilly and Company.: Geographical Revenue
Figure 25 F. Hoffmann-La Roche Ltd: Key Financials
Figure 26 F. Hoffmann-La Roche Ltd: Segmental Revenue
Figure 27 F. Hoffmann-La Roche Ltd: Geographical Revenue
Figure 28 Merck & Co., Inc.: Key Financials
Figure 29 Merck & Co., Inc.: Segmental Revenue
Figure 30 Merck & Co., Inc.: Geographical Revenue
Figure 31 Novartis AG: Key Financials
Figure 32 Novartis AG: Segmental Revenue
Figure 33 Novartis AG: Geographical Revenue
Figure 34 Pfizer Inc.: Key Financials
Figure 35 Pfizer Inc.: Segmental Revenue
Figure 36 Pfizer Inc.: Geographical Revenue
